Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
|
|
1. |
Registration Statement (Form S-8 No. 333-212363) pertaining to the 2012 Equity Incentive Plan, 2016 Stock Incentive Plan, and 2016 Employee Stock Purchase Plan of Syros Pharmaceuticals, Inc., |
|
|
2. |
Registration Statements (Form S-8 Nos. 333-253861, 333-216821, 333-223574, 333-230116 and 333-236895) pertaining to the 2016 Stock Incentive Plan and 2016 Employee Stock Purchase Plan of Syros Pharmaceuticals, Inc., |
|
|
3. |
Registration Statement (Form S-3 No. 333-222634) of Syros Pharmaceuticals, Inc., |
|
|
4. |
Registration Statement (Form S-3 No. 333-239141) of Syros Pharmaceuticals, Inc., and |
|
|
5. |
Registration Statement (Form S-3 No. 333-251941) of Syros Pharmaceuticals, Inc. |
of our report dated March 15, 2022, with respect to the consolidated financial statements of Syros Pharmaceuticals, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2021.
/s/ Ernst & Young LLP
Boston, Massachusetts
March 15, 2022